FDA approves Freenome's SimpleScreen CRC blood test for colorectal cancer screening in adults 45+
The FDA has approved SimpleScreen CRC, a blood-based test developed by Freenome and commercialized by Abbott, for colorectal cancer screening in adults aged 45 and older at average risk. This test offers a convenient alternative to traditional screen...
